Happy Health Raises $75 Million for Healthcare in the Home: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on August 18th Happy Health...
Fractal Wins US$17M+ Multi-Year AI Deal with a Fortune 500® U.S. Healthcare Organization
NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Fractal Analytics Ltd. (BSE: 544700) (NSE: FRACTAL), a globally recognized enterprise AI company serving Fortune 500® organizations, announced that it has secured a US$17M+ multi-year agreement with a leading U.S. healthcare enterprise to modernize its Data and AI foundation on Databricks platform and support its journey toward...
Harbour BioMed Announces NMPA Approval of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today announced that the National Medical Products Administration (NMPA) of China has approved...
Bowtie Launches Brand-New “StillCover” Plan
Rely on Public Hospitals for Major Illnesses, Choose Private Ones for Minor Procedures Bowtie StillCover Restores the Power of Choice for Patients with "Three Highs" or Diabetes HONG KONG, Aug. 18, 2026 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer, today announced the launch of a new Supplementary Medical Plan — "Bowtie StillCover" (available in Basic and Advance...
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence
SINGAPORE, Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today announced that its BCM3 dual-function production line for antibody intermediates and drug substances of bioconjugates at Singapore site has successfully achieved GMP release. This milestone marks a...
Enginprime Medical Closes $12M Series A Financing
Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development SHANGHAI and HANGZHOU, China, Aug. 18, 2026 /PRNewswire/ -- Enginprime Medical ("Enginprime" or the "Company"), a developer of percutaneous ventricular assist device (pVAD) technology, today announced the closing of a $12M Series A financing round, exclusively led by Qiming Venture...
GROWNSY Launches “Ask a Pediatrician: Baby Congestion” Educational Content with Dr. Molly O’Shea
NEW YORK, Aug. 17, 2026 /PRNewswire/ -- GROWNSY, a baby care brand trusted by more than 3 million households worldwide, today announced "Ask a Pediatrician: Baby Congestion", a week-long educational content series created in collaboration with pediatrician Molly O'Shea, MD, FAAP. The series is designed to help parents better understand common questions around infant nasal congestion, including how...
Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren’s Contracture
- All 56 planned participants enrolled approximately five months after first patient dosing - Topline Phase 2 data expected in late 2026 - Positive data could support expansion of CNT201 into Peyronie's disease and cellulite SEOUL, South Korea, Aug. 17, 2026 /PRNewswire/ -- Connext, a specialty therapeutics company focused on developing innovative therapies for significant unmet medical needs,...
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting
VANCOUVER, BC, Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The study, titled "Evaluating the Effect of Wearing a TENS Device in Nausea Relief," is also known as the WINNER Study. It is registered under ClinicalTrials.gov identifier NCT07720323 and is currently...
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
CAMBRIDGE, Mass., Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in MSCI Global Small Cap Indexes compiled by Morgan Stanley Capital International (MSCI). The change will take effect as of the close of August 31, 2026. MSCI is a...
